Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial.

Tokunaga, Eriko; Miyoshi, Yasuo; Dozono, Koji; Kawaguchi, Tsutomu; Toi, Masakazu

Tokunaga, Eriko; Miyoshi, Yasuo; Dozono, Koji; Kawaguchi, Tsutomu; Toi, Masakazu.

Afiliação

Tokunaga E; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Miyoshi Y; Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Hyogo, Japan.
Dozono K; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
Kawaguchi T; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.
Toi M; Director, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Oncologist ; 29(3): e319-e329, 2024 Mar 04.

Article em En | MEDLINE | ID: mdl-37971418

Assuntos

Aminopiridinas; Benzimidazóis; Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/patologia; Neutrófilos/patologia; Fulvestranto/uso terapêutico; Linfócitos/patologia; Contagem de Linfócitos

Palavras-chave

abemaciclib; absolute lymphocyte count; breast cancer; neutrophil-to-lymphocyte ratio; prognostic factors; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Neoplasias da Mama / Aminopiridinas Limite: Female / Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google